Show
Sort by
-
- Journal Article
- A1
- open access
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib
-
- Journal Article
- A1
- open access
The use of pan-tropomyosin receptor kinase immunohistochemistry as a screening tool for the detection of neurotrophic tropomyosin-related kinase fusions : real-world data from a national multicentric retrospective study
(2022) PATHOBIOLOGY. -
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma
-
GSDME and its role in cancer : from behind the scenes to the front of the stage
-
PIK3CA in breast cancer : a Belgian practical testing guideline
-
Guidelines for the detection of NTRK fusions : a report from the Belgian Molecular Pathology Working Group
-
- Journal Article
- A1
- open access
An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma
-
- Journal Article
- A1
- open access
The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients
-
Next-generation protein analysis in the pathology department
-
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation